CDx Diagnostics®, innovator of the WATS3D® diagnostic tissue test for the detection and surveillance of Barrett’s esophagus (BE), a known precursor to esophageal adenocarcinoma (EAC), today announced positive results from a clinical study evaluating WATS3D (Wide Area Transepithelial Sampling with 3D Tissue Analysis) in detecting residual/recurrent intestinal metaplasia (RRIM) in patients who have undergone BE ablation.
https://www.apnews.com/Globe%20Newswire/6d78fcb6b0997081e88590c957ca7072